On ECHEMI
Home > Drugs > Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

  • Founded in:

    1992-08-21
  • Country:

    China China
  • Address:

    No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Tax NO.:

    91370000614073351Q
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte stimulating factor, which is made from Escherichia coli containing the gene for highly efficient expression of human granulocyte stimulating factor (G-CSF), after fermentation, separation and high purification. Excipients: mannitol; Tween-80; disodium hydrogen phosphate; citric acid.
Name Description Content CAS NO. Registered Holders
Long-acting recombinant human granulocyte-stimulating factor

One of the main cytokines that regulates granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and increases the function of terminally differentiated granulocyte cells.

More

One of the main cytokines that regulates granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and increases the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte stimulating factor, which is made from Escherichia coli containing the gene for highly efficient expression of human granulocyte stimulating factor (G-CSF), after fermentation, separation and high purification. Excipients: mannitol; Tween-80; disodium hydrogen phosphate; citric acid.
Name Description Content CAS NO. Registered Holders
Long-acting recombinant human granulocyte-stimulating factor

This product is human granulocyte stimulating factor (G-CSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte stimulating factor (G-CSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte stimulating factor, which is made from Escherichia coli containing the gene for highly efficient expression of human granulocyte stimulating factor (G-CSF), after fermentation, separation and high purification. Excipients: mannitol; Tween-80; disodium hydrogen phosphate; citric acid.
Name Description Content CAS NO. Registered Holders
Long-acting recombinant human granulocyte-stimulating factor

This product is human granulocyte stimulating factor (G-CSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte stimulating factor (G-CSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Cefoperazone Sodium for Injection
The main ingredient of this product is cefoperazone sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria, including Gram-positive bacteria and Gram-negative bacteria, as well as some anaerobic bacteria. It can resist hydrolysis by a variety of β-lactamases.

More

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria, including Gram-positive bacteria and Gram-negative bacteria, as well as some anaerobic bacteria. It can resist hydrolysis by a variety of β-lactamases.

62893-20-3 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.